Skip to Content

Proposed Rule

Revocation of General Safety Test Regulations That Are Duplicative of Requirements in Biologics License Applications; Correction

Document Details

Information about this document as published in the Federal Register.

Enhanced Content

Relevant information about this document from Regulations.gov provides additional context. This information is not part of the official Federal Register document.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

AGENCY:

Food and Drug Administration, HHS.

ACTION:

Proposed rule; correction.

SUMMARY:

The Food and Drug Administration is correcting a proposed rule entitled “Revocation of General Safety Test Regulations That Are Duplicative of Requirements in Biological License Applications” that appeared in the Federal Register of August, 22, 2014. The document proposed to amend the biologics regulations by removing the general safety test requirements for biological products. The document published with the incorrect title. This document corrects that error.

Start Further Info

FOR FURTHER INFORMATION CONTACT:

Lori J. Churchyard, Center for Biologics Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 71, Rm. 7301, Silver Spring, MD 20993-0002, 240-402-7911.

End Further Info End Preamble Start Supplemental Information

SUPPLEMENTARY INFORMATION:

In the Federal Register of August 22, 2014, in FR Doc. 2014-19888, on page 49727, the following correction is made:

1. On page 49727, in the third column, in the heading of the document, “Revocation of General Safety Test Regulations That Are Duplicative of Requirements in Biological License Applications” is corrected to read “Revocation of General Safety Test Regulations That Are Duplicative of Requirements in Biologics License Applications”.

Start Signature

Dated: September 3, 2014.

Leslie Kux,

Assistant Commissioner for Policy.

End Signature End Supplemental Information

[FR Doc. 2014-21481 Filed 9-9-14; 8:45 am]

BILLING CODE 4164-01-P